RESPIRATORY PARALYSIS

This adverse event was reported 160 times

RESPIRATORY PARALYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROPOFOL INJECTABLE EMULSION 1 0.0090
1 NALBUPHINE HYDROCHLORIDE 2 0.0088
2 NEOSTIGMINE METHYLSULFATE 2 0.0046
3 BUPRENORPHINE HCL 3 0.0034
4 NELARABINE 2 0.0021
5 SUCCINYLCHOLINE CHLORIDE 3 0.0013
6 VECURONIUM BROMIDE 2 0.0013
7 COLISTIMETHATE SODIUM 2 0.0012
8 BETAXOLOL 1 0.0012
9 FLUTAMIDE 1 0.0010
See all drugs enriched for association with RESPIRATORY PARALYSIS